From March 11, 2024 to March 31, 2024, the company has repurchased 611,267 shares, representing 0.15% for CNY 17.01 million. With this, the company has completed the repurchase of 611,267 shares, representing 0.15% for CNY 17.01 million under the buyback announced on March 12, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26.78 CNY | -1.87% | -2.44% | -17.63% |
20/05 | Wall Street Cues, Central Bank Outlooks Lift Asian Stock Markets | MT |
29/04 | Liaoning Chengda Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.63% | 1.56B | |
-0.92% | 89.87B | |
-1.05% | 37.57B | |
-11.20% | 32.75B | |
+61.85% | 26.47B | |
-20.75% | 14.25B | |
-6.35% | 12.99B | |
-11.42% | 11.93B | |
-47.67% | 10.84B | |
+5.99% | 9.11B |
- Stock Market
- Equities
- 688739 Stock
- News Liaoning Chengda Biotechnology Co.,Ltd.
- Tranche Update on Liaoning Chengda Biotechnology Co.,Ltd.'s Equity Buyback Plan announced on March 12, 2024.